Skip to content

Study on the effect of Shugan Tiaoshen integrated acupuncture and moxibustion in the treatment of PCOS with mental disorders

Study on the effect of Shugan Tiaoshen integrated acupuncture and moxibustion in the treatment of PCOS with mental disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000063
Enrollment
Unknown
Registered
2024-05-15
Start date
2024-05-16
Completion date
Unknown
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Interventions

Experimental group:acupuncture\moxibustion\Intradermal needles\micropuncture

Sponsors

Department of Acupuncture and Moxibustion, Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of PCOS traditional Chinese and Western medicine, and SAS and/or SDS greater than 50 points and less than 70 points. (2) Patients between the ages of 18~45 years old. (3) Willing to accept the prescribed method of treatment, cooperate with the completion of relevant scale examinations, and sign the informed consent form. Patients who meet the above three criteria at the same time can be included in this research project.

Exclusion criteria

Exclusion criteria: (1) Patients with gynecological acute infectious diseases, endometriosis, premature ovarian failure, and ovarian cysts; (2) Patients with serious primary diseases or mental abnormalities such as blood vessels, liver and kidney and hematopoietic system; (3) The patient has used hormone drugs in the past 3-6 months and has tumors with abnormal secretion of sex hormones; (4) Lactating and pregnant patients; (5) Those who are unwilling or refuse to cooperate with the questionnaire; (6) Patients with contraindications to acupuncture, such as local skin ulceration infection or high fever and inflammatory diseases. Any one of these is excluded.

Design outcomes

Primary

MeasureTime frame
SAS/SDS;HAMA/HAMD;PCOSSQ-Chi;

Secondary

MeasureTime frame
General physical condition;TCM syndrome type integral;Laboratory indicators;Ovulation, menstruation;

Countries

China

Contacts

Public ContactZhijun Ye

Guangdong Hospital of Traditional Chinese Medicine

1029497354@qq.com18138943802

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026